Results 51 to 60 of about 9,550 (129)

Intensification or diversification: responses by anti health-pass entrepreneurs to French government announcements. [PDF]

Int J Health Econ Manag, 2023
Lévêque C, Megzari H.
europepmc   +1 more source

Ce que dit un frontispice sur la réception des contes de fées

, 2014
F. Gevrey
semanticscholar   +1 more source

Rapid microbial viability assay using scanning electron microscopy: a proof-of-concept using Phosphotungstic acid staining. [PDF]

Comput Struct Biotechnol J, 2023
Zmerli O, Bellali S, Haddad G, Hisada A, Ominami Y, Raoult D, Bou Khalil J.   +6 more
europepmc   +1 more source

Editorial. [PDF]

Z Vgl Polit, 2020
Lauth HJ, Suda M, Mohamad-Klotzbach C.
europepmc   +1 more source

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings. [PDF]

CJC Open, 2021
Quinn AE, Ronksley PE, Bresee L, Au F, Wick J, Leung AA, McBrien KA, Manns BJ, Beall RF.   +8 more
europepmc   +1 more source

Prevalence, Characteristics, and Determinants of Suboptimal Care in the Initial Management of Community-Onset Severe Bacterial Infections in Children.

JAMA Netw Open, 2022
Lorton F, Chalumeau M, Martinot A, Assathiany R, Roué JM, Bourgoin P, Chantreuil J, Boussicault G, Gaillot T, Saulnier JP, Caillon J, Gras-Le Guen C, Launay E.   +12 more
europepmc   +1 more source

How can we minimise the use of regular oral corticosteroids in asthma? [PDF]

Eur Respir Rev, 2020
Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devillier P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P.   +18 more
europepmc   +1 more source

Consequences of school closure on access to education: Lessons from the 2013-2016 Ebola pandemic. [PDF]

Int Rev Educ, 2021
Smith WC.
europepmc   +1 more source

Health laboratory licensing: a policy and best-practice analysis. [PDF]

Bull World Health Organ
Huber M, Andreyeva M, Presser LD, Salvi Le Garrec Zwetyenga J.   +3 more
europepmc   +1 more source

Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study. [PDF]

Acta Derm Venereol
Calabrese L, Cinotti E, D'Onghia M, Cartocci A, Rubegni P, Maccari F, Boulard C, Reguiai Z, Becherel PA, Jacobzone C, Begon E, Fite C, Walls B, Liegeon AL, Parier J, Chaby G, Perrot JL, Omcci Group.   +17 more
europepmc   +1 more source